首页> 美国卫生研究院文献>Molecular Therapy. Nucleic Acids >Gene Silencing Using 4′-thioDNA as an Artificial Template to Synthesize Short Hairpin RNA Without Inducing a Detectable Innate Immune Response
【2h】

Gene Silencing Using 4′-thioDNA as an Artificial Template to Synthesize Short Hairpin RNA Without Inducing a Detectable Innate Immune Response

机译:基因沉默使用4-thioDNA作为人工模板合成短发夹RNA而不会引起可检测的先天免疫应答。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of a versatile technique to induce RNA interference (RNAi) without immune stimulation in vivo is of interest as existing approaches to trigger RNAi, such as small interfering RNA (siRNA) and plasmid DNA (pDNA) expressing short hairpin RNA (shRNA), present drawbacks arising from innate immune stimulation. To overcome them, an intelligent shRNA expression device (iRed) designed to induce RNAi was developed. The minimum sequence of iRed encodes only the U6 promoter and shRNA. A series of iRed comprises a polymerase chain reaction (PCR)-amplified 4′-thioDNA in which any one type of adenine (A), guanine (G), cytosine (C), or thymine (T) nucleotide unit was substituted by each cognate 4′-thio derivatives, i.e., dSA iRed, dSG iRed, dSC iRed, and ST iRed respectively. Each modified iRed acted as a template to transcribe shRNA with RNAi activity. The highest shRNA yield was generated using dSC iRed that exerted gene silencing activity in an orthotopic mouse model of mesothelioma. Reducing the minimal structure required to transcribe shRNA and the presence of the 4′-thiomodification synergistically function to abrogate innate immune response induced by dsDNA. The iRed will introduce a new approach to induce RNAi without inducing a detectable innate immune response.
机译:由于现有的触发RNAi的方法,例如表达短发夹RNA(shRNA)的小干扰RNA(siRNA)和质粒DNA(pDNA),在体内无需免疫刺激即可诱导通用RNA干扰(RNAi)的通用技术的发展引起了人们的关注。存在由先天免疫刺激引起的缺点。为了克服它们,开发了一种旨在诱导RNAi的智能shRNA表达设备(iRed)。 iRed的最小序列仅编码U6启动子和shRNA。一系列iRed包含聚合酶链反应(PCR)扩增的4'-thioDNA,其中腺嘌呤(A),鸟嘌呤(G),胞嘧啶(C)或胸腺嘧啶(T)核苷酸单元中的任何一种均被各自取代同源的4'-硫代衍生物,即分别为dSA iRed,dSG iRed,dSC iRed和ST iRed。每个修饰的iRed充当模板转录具有RNAi活性的shRNA。使用在间皮瘤原位小鼠模型中发挥基因沉默活性的dSC iRed,可产生最高的shRNA产量。减少转录shRNA所需的最小结构和4'-硫基修饰的协同作用,可消除dsDNA诱导的先天免疫应答。 iRed将引入一种新方法来诱导RNAi,而不诱导可检测的先天免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号